NWRD-06

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameNWRD-06

Drug Alias NameNWRD06裸质粒DNA注射液NWRD-06NWRD06NWRD 06

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineCell and gene therapy > Gene therapy > PlasmidVaccines > Application > Therapeutic vaccine +[4]

Mechanisms of ActionGlypican-3 gene transferenceImmunostimulants

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesNewish Technology (Beijing) Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesNewish Technology (Beijing) Co Ltd

Inactive CompaniesNuowei Technology (Taizhou) Co Ltd

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A